Pharma Industry
Pharma Industry 16/01/2012
Pfizer tests a concept that could modernize drug studies
For the pharmaceutical industry, it’s another part of the business that cries out for change: the complex and costly human studies involved in developing new medicines.
Pharma Industry 13/01/2012
Battling borderless bugs
Western and emerging-market drug firms are invading each other’s turf.
Pharma Industry 12/01/2012
Follow the money: Where pharma is investing
A new report underscores how drugmakers are seeking low-cost venues for their most labor-intensive activities.
Pharma Industry 12/01/2012
A lack of progress? Blame it on the FDA
An overwhelming majority of CEOs blame the FDA for slowing the growth of their companies.
Pharma Industry 11/01/2012
GeoVax Labs' CEO update letter to shareholders
"During 2011, GeoVax achieved steady progress in developing our HIV/AIDS vaccines and continued to lay a solid foundation for continued clinical and corporate success. While we are pleased with our results, our goal for 2012 is to achieve even greater and more timely progress."
Pharma Industry 10/01/2012
Reluctant placebo supplies undermining independent trials
Without a legal obligation to provide placebos to match their marketed drugs, the pharmaceutical industry has de-facto control over drug trials.
Pharma Industry 10/01/2012
Bristol-Myers Squibb to acquire Inhibitex
Strategic acquisition supports long-term growth potential of the company; Builds on company’s strong legacy and commitment in virology; Enhances company’s broad HCV portfolio with addition of INX-189, a potent NS5B nucleotide.
Pharma Industry 05/01/2012
DFH Pharma to collaborate with CiVentiChem to develop second-generation HIV maturation inhibitor drugs
Maturation inhibitors are a novel class of antiretroviral drug candidates that inhibit HIV-1 replication by interfering with the maturation of the HIV-1 virus.
Pharma Industry 23/12/2011
Pharma outsourcing over one third of trials
More than one third of clinical trials conducted by pharmaceutical companies are now being outsourced, a new report has found.
Pharma Industry 22/12/2011
Pharma asks the money question earlier for new drugs
GlaxoSmithKline Plc executive German Pasteris is in charge of an Alzheimer's treatment that is years from reaching the market, if it ever does. But he already wants to make sure the global healthcare system will pay for it.
Pharma Industry 22/12/2011
Pharma social media activity varies hugely - report
The analysis of social network presence focuses on the top 100 pharma companies in terms of traditional sales force and marketing channel spending.
Pharma Industry 16/12/2011
Tough 2012 for pharma but industry still rated highly
The pharmaceutical sector will continue to experience significant operating challenges in 2012 but while issuing a negative outlook, it will still be one of the highest-rated industries.
Pharma Industry 07/12/2011
Theratechnologies to discontinue COPD clinical program and accelerate path to profitability
The Company will now focus its efforts on tesamorelin's significant potential for the treatment of excess abdominal fat in HIV patients with lipodystrophy.
Pharma Industry 07/12/2011
Merck & Co pushing R&D in China with new facility
US giant Merck & Co is establishing an Asian R&D headquarters in Beijing, as part of a $1.5 billion investment into research in China over the next five years.
Pharma Industry 07/12/2011
'Me-too' pharma firms will 'disappear' - Roche's Schwan
Drugmakers whose offerings do not offer any genuine value are going to "literally disappear" over the next decade, according to Roche's chief executive.
Pharma Industry 07/12/2011
Consumers want info from websites, not Facebook
Nearly two in five Europeans would like to learn more about medicines directly from drugmakers, getting such info from websites.
Pharma Industry 06/12/2011
Pharmasset poised to pay 20% with Gilead deal closing: real M&A
After attracting a record windfall for a drug takeover, Pharmasset Inc. is now offering the biggest annualized return of any U.S. deal for traders willing to bet on smooth development of its experimental hepatitis C treatment.
Pharma Industry 03/12/2011
Drugmakers go from abundance to scarcity
It is no secret that the pharmaceutical industry has experienced thinning pipelines, patent expirations and massive consolidation over the past few years. But just how bad has it been? Despite some bright spots, pretty bad.
Pharma Industry 01/12/2011
Nearly 90 medicines and vaccines in development for HIV/AIDS
America’s biopharmaceutical research companies are testing 88 medicines and vaccines to treat or prevent HIV/AIDS and related conditions.
Pharma Industry 01/12/2011
Russian drugmakers appeal to Putin over prices
The Ministry of Health and the Federal Tariff Service will not permit them to increase the prices of medicines included in the new list of "vital and essential drugs".
More...
